The screening performed well, especially in women at high risk of aggressive BRCA1-associated breast cancer, by detecting invasive tumors ≤1 cm without nodal involvement and effectively avoiding interval invasive cancers with low recall rates. Here, BRCA1 is linked to breast carcinoma.